ArticleCureus2022

Predictors and Long-Term Outcomes for Diffuse Large B-Cell Lymphoma (DLBCL) Patients Undergoing Surgery Prior to Systemic Therapy: A Nationwide Analysis.

Urwat Vusqa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.